Alogliptin

Alogliptin

drugbox
IUPAC_name = 2-({6- [(3"R")-3-aminopiperidin-1-yl] -3-methyl-2,4-dioxo-
3,4-dihydropyrimidin-1(2"H")-yl}methyl)benzonitrile



CAS_number = 850649-62-6
ATC_prefix =
ATC_suffix =
PubChem = 11450633
DrugBank =
C=18|H=21|N=5|O=2
molecular_weight = 339.39 g/mol
smiles = N#Cc3ccccc3CN1C(=O)N(C)C(=O)/C=C/1N2CCC [C@@H] (N)C2
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration = Oral

Alogliptin (codenamed SYR-322) is an investigational anti-diabetic drug in the DPP-4 inhibitor class,cite journal |author=Feng J, Zhang Z, Wallace MB, "et al" |title=Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV |journal=J. Med. Chem. |volume=50 |issue=10 |pages=2297–300 |year=2007 |pmid=17441705 |doi=10.1021/jm070104l] being developed by Takeda Pharmaceutical Company. Takeda has submitted a New Drug Application for alogliptin to the U.S. Food and Drug Administration, after positive results from Phase III clinical trials.cite press release | url = http://www.takeda.com/press/article_28864.html | title = Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. | date = January 4 2008 | accessdate = 2008-01-09 | publisher = Takeda Pharmaceutical Company]

References


Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Look at other dictionaries:

  • Development of dipeptidyl peptidase-4 inhibitors — Dipeptidyl peptidase 4 inhibitors (DPP 4 inhibitors) are enzyme inhibitors that inhibit the enzyme dipeptidyl peptidase 4 (DPP 4) and are a potent treatment for type 2 diabetes. Inhibition of the DPP 4 enzyme prolongs and enhances the activity of …   Wikipedia

  • Anti-diabetic medication — Anti diabetic medications treat diabetes mellitus by lowering glucose levels in the blood. With the exceptions of insulin, exenatide, and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral… …   Wikipedia

  • Inhibitoren der Dipeptidylpeptidase 4 — Sitagliptin, Leitsubstanz der neuen (Stand Juli 2007) Antidiabetika Klasse der Dipeptidyl Peptidase 4 Inhibitoren Inhibitoren der Dipeptidylpeptidase 4, auch kurz als DPP4 Inhibitoren, Gliptine oder als Inkretinverstärker bezeichnet, sind… …   Deutsch Wikipedia

  • Dipeptidyl peptidase-4 inhibitor — DPP 4 inhibitors and GLP 1 Inhibitors of dipeptidyl peptidase 4, also DPP 4 inhibitors or gliptins, are a class of oral hypoglycemics that block DPP 4. They can be used to treat diabetes mellitus type 2. The first agent of the class sitagliptin… …   Wikipedia

  • Glipizide — Not to be confused with gliclazide or glyburide. Glipizide Systematic (IUPAC) name N (4 [N (cyclohexylcarbamoyl)sulfamoyl]phenethyl) 5 methylpyrazine 2 carboxamide …   Wikipedia

  • Glimepiride — Systematic (IUPAC) name 3 ethyl 4 methyl N (4 [N ((1r,4r) 4 methylcyclohexylcarbamoyl)sulfamoyl]phenethyl) 2 oxo 2,5 dihydro 1H pyrrole 1 carboxamide Clinical …   Wikipedia

  • Metformin — Chemical structure (top) and ball and stick model (bottom) of metformin System …   Wikipedia

  • Troglitazone — Systematic (IUPAC) name (RS) 5 (4 [(6 hydroxy 2,5,7,8 tetramethylchroman 2 yl)methoxy]benzyl)thiazolidine 2,4 dione Clinical data Pre …   Wikipedia

  • Pioglitazone — Systematic (IUPAC) name (RS) 5 (4 [2 (5 ethylpyridin 2 yl)ethoxy]benzyl)thiazolidine 2,4 dione Clinical data …   Wikipedia

  • Chlorpropamide — Systematic (IUPAC) name 4 chloro N (propylcarbamoyl)benzenesulfonamide Clinical data Trade names Diabin …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”